Evaluation of the Efficacy of an anti-melasma oral supplement by self assessment questionnaires
Reference Product: Pynocare (containing MSCC Complex- Melasma Skin Clear Complexion Complex)
Dr. Fabrice Perin, Spincontrol, Thailand July 2004
Participants:
22 healthy women aged 20-60, with melasma not having any used any treatments for the past 2 months
I:
subjects took oral supplement every day during all the study period of 12 weeks, twice daily after meal; 1 capsule/time, in the morning and in the evening with at least 6 hours between two capsules.
Outcome:
Efficacy rate of 85% in the reduction of the size and intensity of melasma lesions
Conclusion:
PYNOCARE is effective and safe in the treatment of melasma
For the full study, contact us.
1 Comment on Clinical Study – Thailand
[…] Clinically tested in Thailand […]